Navigation Links
ResMed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2013
Date:4/25/2013

SAN DIEGO, April 25, 2013 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced record revenue and income for the quarter ended March 31, 2013.  Revenue for the quarter ended March 31, 2013 was $383.6 million, a 10% increase (also a 10% increase on a constant currency basis) over the quarter ended March 31, 2012.  For the quarter ended March 31, 2013, net income was $84.9 million, an increase of 31% compared to the quarter ended March 31, 2012.  Diluted earnings per share for the quarter ended March 31, 2013 were $0.58, an increase of 32% compared to the quarter ended March 31, 2012. 

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

SG&A expenses were $109.6 million for the quarter ended March 31, 2013, an increase of $7.7 million, or 8% (also an 8% increase on a constant currency basis) compared to the quarter ended March 31, 2012.  SG&A costs were 28.6% of revenue in the quarter ended March 31, 2013, compared to 29.2% for the quarter ended March 31, 2012.
 

R&D expenses were $31.2 million for the quarter ended March 31, 2013, an increase of $2.8 million, or 10% (an 11% increase on a constant currency basis) compared to the quarter ended March 31, 2012.  R&D expenses were 8.1% of revenue in the quarter ended March 31, 2013, consistent with 8.1% for the quarter ended March 31, 2012.

The company amortized acquired intangibles of $2.5 million ($1.9 million, net of tax) during the quarter ended March 31, 2013.  Stock-based compensation costs incurred during the quarter ended March 31, 2013 of $10.2 million ($7.2 million, net of tax) consisted of expenses associated with stock options, restricted stock units, and our employee stock purchase pl
'/>"/>

SOURCE ResMed Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment
2. ResMed Announces Conference Call And Webcast To Discuss Third Quarter 2013 Results
3. ResMed Takes Action to Enforce Patents
4. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
5. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2012
6. ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
7. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2012
8. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
9. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
10. ResMed Launches Narval™ CC Mandibular Repositioning Device in the US
11. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2013)... Dec. 19, 2013 /PRNewswire-iReach/ -- Last week, ... Cardiovascular Research and Education at PinnacleHealth, and ... at PinnacleHealth, performed the first catheter-based valve repair ... approval. The U.S. Food and Drug Administration (FDA) ... the United States in October, providing ...
(Date:12/19/2013)... 2013  Amgen (NASDAQ: AMGN ) today announced ... ffect of PC S K9 Antibody C omp AR ... study evaluating the long-term 52-week safety and efficacy of evolocumab ... of percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) ... "bad" cholesterol, was consistent with the results observed in the ...
(Date:12/19/2013)... Dec. 19, 2013 /PRNewswire-iReach/ -- Microtrac, the global pioneer ... to introduce the Nanotrac Wave Q, a dynamic light ... The Nanotrac Wave Q is the latest in a ... Microtrac.  Engineered with the end user in ... of features that enable the operator to quickly and ...
Breaking Medicine Technology:Harrisburg-based Cardiovascular Institute Performs First MitraClip Procedure in Pennsylvania 2Harrisburg-based Cardiovascular Institute Performs First MitraClip Procedure in Pennsylvania 3Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol 2Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol 3Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol 4Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol 5Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol 6Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol 7Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol 8Introducing the Nanotrac Wave Q, a Particle Size Analyzer that Measures with Unsurpassed Accuracy and Repeatability 2Introducing the Nanotrac Wave Q, a Particle Size Analyzer that Measures with Unsurpassed Accuracy and Repeatability 3
(Date:12/20/2013)... Hospital Pepin Heart Institute and Dr. Kiran C. Patel ... old Clearwater man, has been treated as part of ... Diego-based Cytori Therapeutics, derives stem cells from the patient’s ... parts of the heart. The ATHENA trial is a ... disease. Dr. Charles Lambert, Medical Director of Florida ...
(Date:12/20/2013)... York, NY (PRWEB) December 20, 2013 ... by Quest Diagnostics Inc. (“Quest Diagnostics”), the diagnostic ... Laboratory Corporation of America Holdings Inc. (“LabCorp.”), the ... The settlement concerns the whistleblower lawsuit which ... insurance plans for the payment of "kickbacks" for ...
(Date:12/20/2013)... 2013 SmileCare’s dental team and patients ... of sick children this year. They donated almost 200 ... Hospital. , Orthodontist Geoffrey Kopecky, DDS, teamed ... Drive organizers to arrange for eight SmileCare offices in ... to become collection sites for the stuffed animals. Dr. ...
(Date:12/20/2013)... On behalf of Best Drug Rehabilitation , ... Social Services (CCSS) in order to help the organization provide ... this holiday season. , Per Wickstrom made ... which is located at 11850 Woodrow Wilson Street in Detroit. ... of the organization’s incredible volunteers as they prepared and served ...
(Date:12/20/2013)... December 20, 2013 The holidays should be ... sometimes the stress of making everything perfect throws a wrench ... of tips to eliminate some of the stress hosts and ... said enough that planning ahead saves loads of stress for ... up a menu for every meal, including breakfasts, drinks and ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Pepin Heart Institute is First in West & Central Florida to Perform a Groundbreaking Stem Cell Clinical Trial for Heart Failure Patients 2Health News:Florida Hospital Pepin Heart Institute is First in West & Central Florida to Perform a Groundbreaking Stem Cell Clinical Trial for Heart Failure Patients 3Health News:Florida Hospital Pepin Heart Institute is First in West & Central Florida to Perform a Groundbreaking Stem Cell Clinical Trial for Heart Failure Patients 4Health News:Zamansky LLC Comments On the Settlement By Quest Diagnostics And LabCorp. Of America Of The Whistle-Blower Lawsuit 2Health News:SmileCare Team, Patients Donate Almost 200 Teddy Bears to Help Children Smile 2Health News:Donation by Best Drug Rehabilitation’s CEO Per Wickstrom to Help Detroit’s Cass Community Social Services (CCSS) Make the Holidays Brighter for Children 2Health News:King Kullen’s Tips for a Stress-Free Holiday 2Health News:King Kullen’s Tips for a Stress-Free Holiday 3Health News:King Kullen’s Tips for a Stress-Free Holiday 4Health News:King Kullen’s Tips for a Stress-Free Holiday 5
... a low-fat, low-calorie diet and getting regular exercise helps shed ... Hutchinson Cancer Research Center has found that when it comes ... most effective when done together as compared to either strategy ... Anne McTiernan, M.D., Ph.D., director of the Prevention Center and ...
... An enzyme essential for DNA replication and repair in humans ... therapy, say researchers at The Scripps Research Institute and Lawrence ... 15, 2011 issue of the journal Cell, focused on a ... are essential to the life of a cell. The findings ...
... A new study by researchers at the University of Alberta ... attack, early exercise as well as prolonged exercise is the ... in the Faculty of Rehabilitation Medicine, and Alex Clark, researcher ... A researchers Don Schopflocher in the School of Public Health, ...
... 2011 During the winter of 2008�, a three-week ... Gaza Strip named "Operation Cast Lead" resulted in hundreds ... During this time children and their families spent ... survival. Although the psychological effects of children,s ...
... 2011 An international consortium of scientists, including ... that the "one-size fits all" strategy of uniformly ... for patients with high on-treatment platelet reactivity does ... and stent thrombosis after percutaneous coronary intervention (PCI). ...
... Spring Harbor, N.Y. -- One way of discovering a gene,s ... loss of its activity affects an organism. If a gene ... will kill the organism before the gene,s function can be ... this problem by using RNA interference (RNAi) technology to temporarily ...
Cached Medicine News:Health News:Study finds diet plus exercise is more effective for weight loss than either method alone 2Health News:Study finds diet plus exercise is more effective for weight loss than either method alone 3Health News:Study suggests enzyme crucial to DNA replication may provide potent anti-cancer drug target 2Health News:Study suggests enzyme crucial to DNA replication may provide potent anti-cancer drug target 3Health News:Study suggests enzyme crucial to DNA replication may provide potent anti-cancer drug target 4Health News:Heart needs work after heart attack: U of A Study challenges the notion that the heart must rest 2Health News:Teachers-based intervention provides stress resistance in war-exposed children 2Health News:Antiplatelets: 1 person, 1 dose? 2Health News:CSHL team perfects non-lethal way of switching off essential genes in mice 2Health News:CSHL team perfects non-lethal way of switching off essential genes in mice 3
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
Sterile cordless eraser tips, packsize is 10/box....
Curved shafts with 2.0 mm wide serrated tips and 0.4 mm pin in upper jaw. Serrated cross action handle with dull finish....
Angled insertion forcep used for the Hydroview lens. Manufactured in titanium....
Medicine Products: